Evolent Health (EVH) Receivables - Other (2015 - 2021)

Evolent Health's Receivables - Other history runs 7 years deep, the most recent figure standing at $190000.0 for Q1 2021.

• On a quarterly basis, Receivables - Other fell 89.16% year-over-year to $190000.0 in Q1 2021; TTM through Mar 2021 was $190000.0, a 89.16% decrease from a year earlier, with the FY2020 full-year figure at $329000.0, down 81.21% from the prior year.
• Receivables - Other fell to $190000.0 in Q1 2021 per EVH's latest filing, from $329000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $10.1 million in Q3 2019 and bottomed at $190000.0 in Q1 2021.
• The 5-year median for Receivables - Other is $4.9 million (2017), against an average of $4.5 million.
• Across the five-year window, Receivables - Other soared 35.44% in 2018 and sank 93.33% in 2020, its largest moves.
• Year by year, Receivables - Other stood at $3.4 million in 2017, then sank by 37.4% to $2.1 million in 2018, then declined by 16.7% to $1.8 million in 2019, then slumped by 81.21% to $329000.0 in 2020, then sank by 42.25% to $190000.0 in 2021.
• Per Business Quant, the three latest EVH Receivables - Other figures stand at $190000.0 (Q1 2021), $329000.0 (Q4 2020), and $671000.0 (Q3 2020).